Cytori to Webcast Fourth Quarter and Year End Financial Results on March 7
SAN DIEGO -- February 28, 2013
Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its fourth
quarter and year end financial results and business update on Thursday, March
7, 2013 at 5:00 PM Eastern Time.
The dial-in information is as follows:
Dial-In Number: +1.877.402.3914
Conference ID: 11509895
Prior to the webcast at approximately 4:05 PM Eastern Time on March 7, Cytori
will issue its year end earnings release which will review Cytori's fourth
quarter and full year performance. CEO Chris Calhoun will give detailed
remarks at the start of the call. Please note, Cytori will not be providing a
shareholder letter as in past quarters.
The webcast will be available both live and by replay two hours after the call
under “Webcasts” on the Company's Investor Relations website
Cytori Therapeutics is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and
repair soft tissue defects. Our scientific data suggest ADRCs improve blood
flow. As a result, we believe these cells can be applied across multiple
“ischemic” conditions. These therapies are made available to the physician and
patient at the point-of-care by Cytori’s proprietary technologies and
products, including the Celution® System product family. www.cytori.com
Megan McCormick, +1.858.875.5279
Press spacebar to pause and continue. Press esc to stop.